CytoSorbents Corporation (CTSO)

[biotech48]

lakersrback, I answered this same quesion before, for you, under pearsby. The study under Doctor Sigrun Friesecke in Griefwald Germany, " Preliminary key findings of the CytoSorb® Greifswald study: 28-day-survival was 41%, an approximately 30-40% absolute improvement in survival compared to what was expected (0-10%) Resolution of shock, the main cause for mortality in this patient population, was achieved in 68% of the patients with CytoSorb® therapy, which translated into improvement in clinical outcomes Reduction of IL-6, one of the cytokines most closely associated with severity of illness, inflammation, and mortality in sepsis, decreased rapidly from initial mean values of approximately 87,000 ." This was a sepsis study with refractory sepsis, where none of the patients were expected to live and after being treated with Cytosorb, the 28 day survival was 41%. Of course, the company will eventually do a much larger trial.